Showing results (161-170 of 308) with videos related to
Sort By:
Pageof 31
Pharmaceutical Medicine|January 15, 2020
Adverse Drug Reactions Involving Protein Kinase Inhibitors: A French Pharmacovigilance Database Study Comparing Safety in Younger and Older Patients (≥ 75 years) with CancerVincent Clapes, Vanessa Rousseau, Fabien Despas, et al.Pharmaceutical Medicine|January 15, 2020
Peptide-Based Therapeutics for OncologyElizaveta Fisher, Kirill Pavlenko, Alexander Vlasov, et al.Pharmaceutical Medicine|January 15, 2020
Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept in Europe: Evaluation of Risk-Minimization MeasuresLaurie J Zografos, Elizabeth Andrews, Daniel L Wolin, et al.Pharmaceutical Medicine|January 15, 2020
Reflections on the Evolution of Patient Engagement in Drug DevelopmentKenneth GetzPharmaceutical Medicine|July 5, 2022
Potential Channeling Bias in the Evaluation of Cardiovascular Risk: The Importance of Comparator Selection in Observational ResearchHu Li, Francis Mawanda, Lucy Mitchell, et al.Pharmaceutical Medicine|April 13, 2022
Chaos to Clarity: Pragmatic Approaches to Overcome Challenges for Successful Implementation of Additional Risk Minimisation Measures in the European Union and the UK by a Marketing Authorisation HolderKalindi Hapani, Nipa Parikh, Krystle Pianka, et al.Pharmaceutical Medicine|April 5, 2022
Medicines Regulatory Science Expertise in Africa: Workforce Capacity Development and Harmonisation Activities Towards the Establishment of the African Medicines AgencyBakani Mark Ncube, Admire Dube, Kim WardPharmaceutical Medicine|December 4, 2023
Evaluation of Physician Knowledge of Safety and Safe Use Information for Intravitreal Aflibercept Injection in Europe: A Second Survey of Physicians Following Dissemination of Updated Risk-Minimization MaterialsLaurie J Zografos, Elizabeth Andrews, Dan L Wolin, et al.Pharmaceutical Medicine|July 8, 2023
The Risk Evaluation and Mitigation Strategy (REMS) Public Dashboard: Improving Transparency of Regulatory ActivitiesGita A Toyserkani, Joann H Lee, Esther H ZhouPharmaceutical Medicine|February 21, 2020
Proposal for a New Stereochemically Informative Nonproprietary Drug Naming SystemJoseph GalPageof 31